Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Andrew Bindman named new AHRQ director

Andrew Bindman, MD, has been named director of the U.S. Agency for Healthcare Research and Quality (AHRQ), replacing Sharon B. Arnold, PhD.

Wyeth, Pfizer to pay $784M to settle Medicaid fraud claims

Pfizer and Wyeth have agreed to pay $784.6 million to resolve allegations of underpaying rebates to Medicaid.

Stronger together: The coupling up of the healthcare industry

It seems that everyone is pairing up these days. From Abbott reaching a deal to buy St. Jude Medical for $25 billion, Sanofi making an offer to Medivation for $9.3 billion and AbbVie signing a deal with Stemcnetrx for $5.8 billion.

Why bigger is better business for health care companies

Companies are increasingly viewing scaling up as the only way to stay competitive, according to the New York Times.

Joint Commission announces new standards on treating eating disorders

Behavioral health care organizations treating eating disorders will be subject to several additional requirements from the Joint Commission.

CMS: Prescription drug costs are growing problem

Drug prices rose 12 percent in 2015 and national spending on cancer and hepatitis drugs and other special medicines has doubled in the past five years.

CMS clarifies Medicaid rules on ex-prisoners in halfway houses

New CMS guidelines for state health officials means 96,000 ex-prisoners currently living in halfway houses can receive Medicaid services.

Senate bill would cap Medicare drug costs at $7,500

Medicare enrollees would have out-of-pocket drug costs capped at $7,500 under a proposed Senate bill that would take effect in 2018.

Displaying 6145 - 6152 of 8455

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.